Determinants of each domain of the Short Physical Performance Battery in COPD

Bernabeu-Mora, Roberto; Giménez-Giménez, Luz María; Montilla-Herrador, Joaquina; García-Guillamón, Gloria; García-Vidal, José Antonio; Medina-Mirapeix, Françesc

doi:10.2147/copd.s138402

Cited by 32 publications

(31 citation statements)

References 44 publications

(63 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The SPPB has been used to monitor physical performance in both healthy community-dwelling older adults as well as hospitalized patients. (17)(18)(19)(20) This measure is advantageous in that minimal equipment is required to perform the test, and objective data is provided on muscle strength, gait speed and standing balance. In addition, specific components of the SPPB can independently predict the risk of declines in activities of daily living,(21) falls, (22) hospitalisation (23) and mortality.…”

Section: Discussionmentioning

confidence: 99%

The Diagnostic Value of the Short Physical Performance Battery for Sarcopenia

Phu

Kirk

Hassan

et al. 2020

Preprint

View full text Add to dashboard Cite

BACKGROUND: Sarcopenia is defined as the age-related loss of muscle mass, strength and physical performance. The original European Working Group on Sarcopenia in Older Persons (EWGSOP1) definition, and its revision (EWGSOP2), provide new cut-points and alternate measures for sarcopenia diagnosis. However, sarcopenia is rarely diagnosed in clinical settings owing to its labour-intensive screening process. Given the Short Physical Performance Battery (SPPB) is a quick, easily administrable and objective measure of muscle strength and physical performance, both of which are key components of sarcopenia, this study examined the diagnostic value of the SPPB for this muscle disease.METHODS: A cross-sectional analysis of 294 community-dwelling older persons (≥65 years) was conducted. Appendicular lean body mass [(ALM) divided by height squared (ALM/h 2 )], muscle strength (handgrip/sit to stand), and physical performance [gait speed, timed up and go (TUG) and SPPB] were assessed using validated procedures, while participants were diagnosed with sarcopenia following the EWGSOP1 and EWGSOP2 criteria. Diagnostic ability of the SPPB independently and combined with ALM/h 2 for sarcopenia was determined using area under the curve (AUC). Potential cut-points were identified, and sensitivity and specificity calculated.RESULTS: Prevalence of sarcopenia ranged from 4 to 16% depending on the definition. The SPPB demonstrated moderate (AUC = 0.644-0.770) value in diagnosing sarcopenia, and a cut-point of ≤8points in SPPB performance resulted in high sensitivity (82-100%) but low specificity (36-41%) for diagnosing those with severe sarcopenia.CONCLUSIONS: The SPPB displayed acceptable value in diagnosing older adults with severe sarcopenia. Moreover, the high sensitivity of the SPPB when using the cut-point of ≤8 suggests it may be a favourable screening tool for sarcopenia in clinical settings where ALM measurements are not available.

show abstract

Section: Discussionmentioning

confidence: 99%

The Diagnostic Value of the Short Physical Performance Battery for Sarcopenia

Phu

Kirk

Hassan

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The inclusion criterion was a diagnosis of stable-stage COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), as updated in 2017. The exclusion criteria were as follows: recent exacerbation of COPD within the 4 weeks preceding the test; limitations on walking and performing the sit-to-stand action, including predominant neurological or musculoskeletal limitation (such as hemiplegia and injury or pathology at lower limb); lower limb joint disease or surgery within the 3 months prior to the test; unstable cardiac condition within the 4 months prior to the test 5 , 14 and long-term oral corticosteroid therapy. The study was approved by the research ethics committees of the First Hospital of China Medical University and the First Hospital of Dalian Medical University, and written informed consent was obtained from all patients.…”

Section: Methodsmentioning

confidence: 99%

“… 19 The average value of the final two trials on each side was documented as the maximal isometric force generated on each side, and the average forces of the two sides were added to derive the bilateral strength, the QMS. 14 , 19 …”

Section: Methodsmentioning

confidence: 99%

“…After a researcher explained the requirements and precautions to the participant, the participant was asked to sit with his or her feet exactly flat on the ground and his or her upper limbs folded across his or her chest and then to stand up all the way and sit down again without using his or her arms. 5 , 9 , 14 , 20 The participant was asked to repeat this sit-to-stand action five times as quickly as possible, and the time taken to complete the five repetitions was recorded. 5 Then, the participant was asked to repeat as many of the sit-to-stand actions as possible in 30 seconds, and the maximum number completed was recorded.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients

Zhang¹,

Li²,

Li³

et al. 2018

COPD

View full text Add to dashboard Cite

PurposeThe sit-to-stand test (STST) has been used to evaluate the exercise tolerance of patients with COPD. However, mutual comparisons to predict poor exercise tolerance have been hindered by the variety of STST modes used in previous studies, which also did not consider patients’ subjective perceptions of different STST modes. Our aim was to compare the five-repetition sit-to-stand test (5STS) with the 30-second sit-to-stand test (30STS) for predicting poor performance in the six-minute walking test and to evaluate patients’ subjective perceptions to determine the optimal mode for clinical practice.Patients and methodsPatients with stable COPD performed 5STS, 30STS and the 6MWT and then evaluated their feelings about the two STST modes by Borg dyspnea score and a questionnaire. Moreover, we collected data through the pulmonary function test, mMRC dyspnea score, COPD assessment test and quadriceps muscle strength (QMS). A receiver operating characteristic curve analysis of the 5STS and 30STS results was used to predict 6-minute walk distance (6MWD) <350 m.ResultsThe final analysis included 128 patients. Similar moderate correlations were observed between 6MWT and 5STS (r=−0.508, P<0.001) and between 6MWT and 30STS (r=0.528, P<0.001), and there were similar correlations between QMS and 5STS (r=−0.401, P<0.001) and between QMS and 30STS (r=0.398, P<0.001). The 5STS and 30STS score cutoffs produced sensitivity, specificity and positive and negative predictive values of 76.0%, 62.8%, 56.7% and 80.3% (5STS) and 62.0%, 75.0%, 62.0% and 75.0% (30STS), respectively, for predicting poor 6MWT performance. The 5STS exhibited obvious superiority in terms of the completion rate and the subjective feelings of the participants.ConclusionAs a primary screening test for predicting poor 6MWD, the 5STS is similar to the 30STS in terms of sensitivity and specificity, but the 5STS has a better patient experience.

show abstract

“…The SPPB has been used to monitor physical performance in both healthy community-dwelling older adults as well as hospitalized patients. (17)(18)(19)(20) Our findings show the SPPB displayed acceptable diagnostic value for sarcopenia. When employing the most common cut-points of ≤6, sensitivity and specificity was 65% and 63%, respectively.…”

Section: Discussionmentioning

confidence: 80%

The Diagnostic Value of the Short Physical Performance Battery for Sarcopenia

Phu

Kirk

Hassan

et al. 2020

Preprint

View full text Add to dashboard Cite

BACKGROUND: Sarcopenia is defined as the age-related loss of muscle mass, strength and physical performance. The original European Working Group on Sarcopenia in Older Persons (EWGSOP1) definition, and its revision (EWGSOP2), provide new cut-points and alternate measures for sarcopenia diagnosis. However, sarcopenia is rarely diagnosed in clinical settings owing to its labour-intensive screening process. Given the Short Physical Performance Battery (SPPB) is a quick, easily administrable and objective measure of muscle strength and physical performance, both of which are key components of sarcopenia, this study examined the diagnostic value of the SPPB for this muscle disease. METHODS: A cross-sectional analysis of 294 community-dwelling older persons (≥65 years) was conducted. Appendicular lean body mass [(ALM) divided by height squared (ALM/h 2 )], muscle strength (handgrip/sit to stand), and physical performance [gait speed, timed up and go (TUG) and SPPB] were assessed using validated procedures, while participants were diagnosed with sarcopenia following the EWGSOP1 and EWGSOP2 criteria. Diagnostic ability of the SPPB independently and combined with ALM/h 2 for sarcopenia was determined using area under the curve (AUC). Potential cut-points were identified, and sensitivity and specificity calculated. RESULTS: Prevalence of sarcopenia ranged from 4 to 16% depending on the definition. The SPPB demonstrated moderate (AUC = 0.644-0.770) value in diagnosing sarcopenia, and a cut-point of ≤8points in SPPB performance resulted in high sensitivity (82-100%) but low specificity (36-41%) for diagnosing those with severe sarcopenia. CONCLUSIONS: The SPPB displayed acceptable value in diagnosing older adults with severe sarcopenia. Moreover, the high sensitivity of the SPPB when using the cut-point of ≤8 suggests it may be a favourable screening tool for sarcopenia in clinical settings where ALM measurements are not available.

show abstract

Determinants of each domain of the Short Physical Performance Battery in COPD

Cited by 32 publications

References 44 publications

The Diagnostic Value of the Short Physical Performance Battery for Sarcopenia

The Diagnostic Value of the Short Physical Performance Battery for Sarcopenia

A comparative study of the five-repetition sit-to-stand test and the 30-second sit-to-stand test to assess exercise tolerance in COPD patients

The Diagnostic Value of the Short Physical Performance Battery for Sarcopenia

Contact Info

Product

Resources

About